<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>y22885ae8vk.txt
<DESCRIPTION>FORM 8-K
<TEXT>
<PAGE>

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                    FORM 8-K

                                 Current Report


     Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

         Date of report (date of earliest event reported): June 30, 2006

                        Phibro Animal Health Corporation
             (Exact name of registrant as specified in its charter)

          New York                  333-64641                    13-1840497
(State or other jurisdiction       (Commission                 (IRS Employer
      of incorporation)            File Number)              Identification No.)

                               65 CHALLENGER ROAD
                        RIDGEFIELD PARK, NEW JERSEY 07660
               (Address of principal executive offices) (Zip Code)

                                 (201) 329-7300
               Registrant's telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))

<PAGE>

Item 8.01

     Phibro Animal Health Corporation and PAHC Holdings Corporation (affiliated
companies) issued a joint press release on June 30, 2006 announcing the
commencement of offers to purchase any and all of the following securities
previously issued, and the solicitation of consents for certain amendments to
the indentures governing such securities:

                        13% Senior Secured Notes due 2007
                    9-7/8% Senior Subordinated Notes due 2008
                        15% Senior Secured Notes due 2010

     A copy of the press release is attached as Exhibit 99.1 and incorporated by
reference into this report.

Item 9.01  Financial Statements and Exhibits.

(d)  Exhibits

Exhibit No.                Description

99.1                       Press Release issued June 30, 2006

<PAGE>

                                   SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                    PHIBRO ANIMAL HEALTH CORPORATION


Dated: June 30, 2006                By:  /s/  Richard G. Johnson
                                         -----------------------
                                    Richard G. Johnson
                                    Chief Financial Officer
                                    (principal financial and accounting officer)

<PAGE>

                                  EXHIBIT INDEX

Exhibit No.                Description

99.1                       Press release issued June 30, 2006
</TEXT>
</DOCUMENT>
